Dataset Information


Determinants of Quality of Life in Myasthenia Gravis Patients

ABSTRACT: Background: Although approximately half of myasthenia gravis (MG) patents achieve remission, for the remaining group MG is often a life-long disease. Better understanding of the determinants of Quality of Life (QoL) in MG is needed to optimize treatment goals in chronic cases. Materials and Methods: We performed a single center cross-sectional study in 339 MG adult patients (64.9% women), with ocular or generalized disease. SF-36 and a structured questionnaire was administered, including information on previous and current MG severity, medications, comorbidities, education, occupation and BMI of the patient. Mean disease duration was 7.5 + 9.3 years. Current age was 51.6 + 18.3 years, 55% had Early-Onset (<50 years) MG. Results: There were no statistically significant differences in mean SF-36 subscores between women and men. Worse MGFA class was related to lower QoL in physical (PCS) and mental (MCS) subscore (p = 0.000 for both). Patients with MGFA I-II class had significantly better QoL in physical and mental subscores than patients with more severe MG (p < 0.005). Late-onset MG patients had worse QoL than EOMG in physical score domain PCS (p = 0.049). Overweight and obese patients had lower PCS (p = 0.002) and MCS (p = 0.038) than patients with normal BMI. University education was related to statistically higher PCS (p = 0.015) and MCS (p = 0.006). QoL in currently employed was better in PCS and MCS (p = 0.000), with white collar workers reporting higher PCS (p = 0.049) than the remaining group. Patients living with family evaluated their MCS (p = 0.015) better than living alone. Moderate physical activity (twice a week) improved PCS (p = 0.045). Conclusion: Our study confirmed that greater severity of symptoms, age, age of onset but also BMI, type of work, education status and physical activity affect QoL in MG.

SUBMITTER: Szczudlik P 

PROVIDER: S-EPMC7538807 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6789047 | BioStudies
2020-01-01 | S-EPMC7093167 | BioStudies
2018-01-01 | S-EPMC6045646 | BioStudies
2018-01-01 | S-EPMC7504973 | BioStudies
1000-01-01 | S-EPMC6338121 | BioStudies
2016-01-01 | S-EPMC5040266 | BioStudies
1000-01-01 | S-EPMC5084798 | BioStudies
2017-01-01 | S-EPMC5837512 | BioStudies
2017-01-01 | S-EPMC5445294 | BioStudies
2018-01-01 | S-EPMC5802666 | BioStudies